Protective effect of pioglitazone on retinal ischemia/ reperfusion injury in rats

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 6, 2013, Pages 3912-3921

  Zhang, Xiao Yan ^a   Xiao, Yi Qin ^a   Zhang, Yu ^a   Ye, Wen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Glia activation; NF B; Pioglitazone; PPAR ; Retinal ischemia reperfusion

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PIOGLITAZONE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENUCLEATION; EVOKED VISUAL RESPONSE; HISTOPATHOLOGY; IMPEDANCE; INTRAOCULAR PRESSURE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINA ISCHEMIA; RETINAL THICKNESS; WESTERN BLOTTING;

GLIA ACTIVATION; NF-ΚB; PIOGLITAZONE; PPAR-Γ; RETINAL ISCHEMIA/REPERFUSION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL COUNT; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOGLYCEMIC AGENTS; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; MALE; NF-KAPPA B; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; RETINAL DISEASES; RETINAL GANGLION CELLS; RETINAL VESSELS; THIAZOLIDINEDIONES;

EID: 84878807048     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-11614     Document Type: Article

References (59)

1. Kuriyama H, Waki M, Nakagawa M, Tsuda M. Involvement of oxygen free radicals in experimental retinal ischemia and the selective vulnerability of retinal damage. Ophthalmic Res. 2001;33:196-202.
2. Prasad SS, Kojic L, Wen YH, et al. Retinal gene expression after central retinal artery ligation: effects of ischemia and reperfusion. Invest Ophthalmol Vis Sci. 2010;51:6207-6219.
3. Lam TT, Abler AS, Tso MO. Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Invest Ophthalmol Vis Sci. 1999;40:967-975.
4. Ju WK, Lindsey JD, Angert M, Patel A, Weinreb RN. Glutamate receptor activation triggers OPA1 release and induces apoptotic cell death in ischemic rat retina. Mol Vis. 2008;14:2629-2638.
5. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci. 1999;40:2697-2705.
6. Cho KJ, Kim JH, Park HY, Park CK. Glial cell response and iNOS expression in the optic nerve head and retina of the rat following acute high IOP ischemia-reperfusion. Brain Res. 2011;1403:67-77.
7. Kota BP, Huang TH, Roufogalis BD. An overview on biological mechanisms of PPARs. Pharmacol Res. 2005;51:85-94.
8. Yi JH, Park SW, Brooks N, Lang BT, Vemuganti R. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res. 2008;1244:164-172.
9. Martin HL, Mounsey RB, Mustafa S, Sathe K, Teismann P. Pharmacological manipulation of peroxisome proliferatoractivated receptor gamma (PPARgamma) reveals a role for anti-oxidant protection in a model of Parkinson's disease. Exp Neurol. 2012;235:528-538.
10. Zhang HL, Xu M, Wei C, et al. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factorkappaB signaling pathway. Neuroscience. 2011;176:381-395.
11. Semple BD, Noble-Haeusslein LJ. Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors. Exp Neurol. 2011;229: 195-197.
12. Gray E, Ginty M, Kemp K, Scolding N, Wilkins A. The PPARgamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function. J Neuroinflammation. 2012;9:63.
13. Swanson CR, Joers V, Bondarenko V, et al. The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation. 2011;8:91.
14. Storer PD, Xu J, Chavis J, Drew PD. Peroxisome proliferatoractivated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J Neuroimmunol. 2005;161:113-122.
15. Shibata N, Kawaguchi-Niida M, Yamamoto T, Toi S, Hirano A, Kobayashi M. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis. Neuropathology. 2008;28:387-398.
16. Sun MH, Pang JH, Chen SL, et al. Retinal protection from acute glaucoma-induced ischemia-reperfusion injury through pharmacologic induction of heme oxygenase-1. Invest Ophthalmol Vis Sci. 2010;51:4798-4808.
17. Hughes WF. Quantitation of ischemic damage in the rat retina. Exp Eye Res. 1991;53:573-582.
18. Sakamoto K, Yonoki Y, Kuwagata M, Saito M, Nakahara T, Ishii K. Histological protection against ischemia-reperfusion injury by early ischemic preconditioning in rat retina. Brain Res. 2004;1015:154-160.
19. Chauhan BC, LeVatte TL, Jollimore CA, et al. Model of endothelin-1-induced chronic optic neuropathy in rat. Invest Ophthalmol Vis Sci. 2004;45:144-152.
20. Johnson TV, Tomarev SI. Rodent models of glaucoma. Brain Res Bull. 2010;81:349-358.
21. Zhang Z, Qin X, Tong N, et al. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Exp Eye Res. 2012;94:98-108.
22. Chen B, Tang L. Protective effects of catalase on retinal ischemia/reperfusion injury in rats. Exp Eye Res. 2011;93:599-606.
23. Lafuente Lopez-Herrera MP, Mayor-Torroglosa S, Miralles de Imperial J, Villegas-Perez MP, Vidal-Sanz M. Transient ischemia of the retina results in altered retrograde axoplasmic transport: neuroprotection with brimonidine. Exp Neurol. 2002;178: 243-258.
24. Jehle T, Wingert K, Dimitriu C, et al. Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci. 2008;49:1056-1064.
25. Shi Y, Wu X, Gong Y, et al. Protective effects of caffeic acid phenethyl ester on retinal ischemia/reperfusion injury in rats. Curr Eye Res. 2010;35:930-937.
26. Ju WK, Kim KY, Park SJ, et al. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res. 2000;881:231-236.
27. Roth S, Pietrzyk Z. Blood flow after retinal ischemia in cats. Invest Ophthalmol Vis Sci. 1994;35:3209-3217.
28. Kim IB, Kim KY, Joo CK, et al. Reaction of Muller cells after increased intraocular pressure in the rat retina. Exp Brain Res. 1998;121:419-424.
29. Grozdanic SD, Sakaguchi DS, Kwon YH, Kardon RH, Sonea IM. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest Ophthalmol Vis Sci. 2003; 44:2597-2605.
30. Vilela C, Cortes V, Vallet M. Electroretinogram: technique and clinical applications [in Spanish]. Rev Neurol. 1998;26:444-447.
31. Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2003;44:4153-4162.
32. Goto Y, Furuta A, Tobimatsu S. Magnesium deficiency differentially affects the retina and visual cortex of intact rats. J Nutr. 2001;131:2378-2381.
33. Sun D, Bui BV, Vingrys AJ, Kalloniatis M. Alterations in photoreceptor-bipolar cell signaling following ischemia/reperfusion in the rat retina. J Comp Neurol. 2007;505:131-146.
34. Rosenbaum DM, Rosenbaum PS, Singh M, et al. Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J Neuroophthalmol. 2001;21:62-68.
35. Block F, Schwarz M. The b-wave of the electroretinogram as an index of retinal ischemia. Gen Pharmacol. 1998;30:281-287.
36. Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33-44.
37. Tsujimoto Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells. 1998;3:697-707.
38. Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50:427-434.
39. Erickson PA, Fisher SK, Guerin CJ, Anderson DH, Kaska DD. Glial fibrillary acidic protein increases in Muller cells after retinal detachment. Exp Eye Res. 1987;44:37-48.
40. Osborne NN, Block F, Sontag KH. Reduction of ocular blood flow results in glial fibrillary acidic protein (GFAP) expression in rat retinal Muller cells. Vis Neurosci. 1991;7:637-639.
41. Wu KH, Madigan MC, Billson FA, Penfold PL. Differential expression of GFAP in early v late AMD: a quantitative analysis. Br J Ophthalmol. 2003;87:1159-1166.
42. Varela HJ, Hernandez MR. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J Glaucoma. 1997;6:303-313.
43. Gallego BI, Salazar JJ, de Hoz R, et al. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma. J Neuroinflammation. 2012;9:92.
44. Wang X, Tay SS, Ng YK. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp Brain Res. 2000;132:476-484.
45. Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci. 2000;20:8693-8700.
46. Tezel G, Yang X. Comparative gene array analysis of TNF-alphainduced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells. Exp Eye Res. 2005;81:207-217.
47. Heneka MT, Sastre M, Dumitrescu-Ozimek L, et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain. 2005;128:1442-1453.
48. Jiang X, Takahashi N, Matsui N, Tetsuka T, Okamoto T. The NFkappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J Biol Chem. 2003;278:919-926.
49. Baichwal VR, Baeuerle PA. Activate NF-kappa B or die? Curr Biol. 1997;7:R94-R96.
50. Choi JS, Kim JA, Kim DH, et al. Failure to activate NF-kappaB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res. 2000;883:60-68.
51. Qin ZH, Chen RW, Wang Y, Nakai M, Chuang DM, Chase TN. Nuclear factor kappaB nuclear translocation upregulates c- Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci. 1999;19:4023-4033.
52. Qin ZH, Tao LY, Chen X. Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. Acta Pharmacol Sin. 2007;28:1859-1872.
53. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 2006;1088:167-175.
54. Nurmi A, Lindsberg PJ, Koistinaho M, et al. Nuclear factorkappaB contributes to infarction after permanent focal ischemia. Stroke. 2004;35:987-991.
55. Zhang W, Potrovita I, Tarabin V, et al. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:30-40.
56. Krohn K, Rozovsky I, Wals P, Teter B, Anderson CP, Finch CE. Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. J Neurochem. 1999;72:1353-1361.
57. Bernardo A, Minghetti L. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr Pharm Des. 2006;12:93-109.
58. Bernardo A, Minghetti L. Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists. PPAR Res. 2008; 2008:864140.
59. Kielian T, Drew PD. Effects of peroxisome proliferatoractivated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003;71:315-325.